STRS Ohio’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-118,900
Closed -$178K 2292
2025
Q1
$178K Sell
118,900
-44,100
-27% -$111K ﹤0.01% 1542
2024
Q4
$385K Buy
163,000
+149,600
+1,116% +$2.63M ﹤0.01% 1302
2024
Q3
$394K Buy
13,400
+1,500
+13% +$34.5K ﹤0.01% 1354
2024
Q2
$147K Buy
11,900
+1,200
+11% +$25.3K ﹤0.01% 1630
2024
Q1
$217K Sell
10,700
-1,300
-11% -$30K ﹤0.01% 1528
2023
Q4
$270K Buy
12,000
+1,200
+11% +$25.4K ﹤0.01% 1479
2023
Q3
$179K Sell
10,800
-1,900
-15% -$37.7K ﹤0.01% 1590
2023
Q2
$311K Buy
12,700
+4,600
+57% +$111K ﹤0.01% 1470
2023
Q1
$195K Hold
8,100
﹤0.01% 1605
2022
Q4
$239K Hold
8,100
﹤0.01% 1546
2022
Q3
$338K Buy
8,100
+600
+8% +$16.2K ﹤0.01% 1464
2022
Q2
$210K Buy
7,500
+400
+6% +$10.1K ﹤0.01% 1598
2022
Q1
$263K Buy
7,100
+3,900
+122% +$165K ﹤0.01% 1636
2021
Q4
$139K Sell
3,200
-5,100
-61% -$267K ﹤0.01% 1827
2021
Q3
$515K Hold
8,300
﹤0.01% 1499
2021
Q2
$709K Buy
8,300
+7,000
+538% +$375K ﹤0.01% 1431
2021
Q1
$58K Buy
+1,300
New +$51.1K ﹤0.01% 2017
2015
Q2
Sell
-6,326
Closed -$83K 1926
2015
Q1
$83K Sell
6,326
-517
-8% -$6.98K ﹤0.01% 1635
2014
Q4
$97K Hold
6,843
﹤0.01% 1548
2014
Q3
$187K Hold
6,843
﹤0.01% 1475
2014
Q2
$275K Buy
+6,843
New +$253K ﹤0.01% 1387

Other funds holding FLNA

STRS Ohio's FLNA Position: Q2 2025 in Review

STRS Ohio sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 118,900 shares — an estimated $178K sold.

STRS Ohio first reported a position in FLNA in Q2 2014 and held it in 21 quarters. The position peaked at $709K in Q2 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • STRS Ohio reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 118,900 Filana Therapeutics shares in Q2 2025, an estimated $178K.
  • STRS Ohio first reported a position in Filana Therapeutics in Q2 2014 and held it in 21 quarters.
  • STRS Ohio's Filana Therapeutics position peaked at $709K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.